[Safety and efficacy of acute stent implantation during endovascular treatment for patients with emergent large vessel occlusion due to intracranial atherosclerotic stenosis]

Zhonghua Nei Ke Za Zhi. 2024 Mar 1;63(3):272-278. doi: 10.3760/cma.j.cn112138-20231031-00274.
[Article in Chinese]

Abstract

Objective: To investigate the efficacy and safety of acute stent implantation during endovascular treatment for patients with emergent large vessel occlusion due to intracranial atherosclerotic stenosis. Methods: A retrospective analysis was carried out on 46 patients with emergent large vessel occlusion due to intracranial atherosclerotic stenosis who received endovascular treatment at the Strategic Support Force Medical Center from January 2015 to August 2022. Twenty-seven patients underwent balloon angioplasty alone and 19 patients underwent acute stent implantation. The baseline characteristics, modified thrombolysis in cerebral infarction (mTICI) score of the responsible vessels, modified Rankin scale (mRS) score 90 days after operation, incidence of symptomatic intracranial hemorrhage and mortality of the two groups were evaluated. Results: The proportion of effective recanalization of the offending vessels (mTICI≥2b) in the acute stenting group was slightly higher than that in the balloon angioplasty group (16/19 vs. 81.5%), but the difference was not statistically significant (P>0.05). Besides, there was no significant difference in the median of mRS between the acute stenting group [3.0(0, 4.0)] and the balloon angioplasty group [4.0(1.0, 5.0)] 90 days after operation (P>0.05). In terms of safety, the incidence of symptomatic intracranial hemorrhage and mortality were comparable between the two groups (P>0.05). Conclusions: The effect of acute stent implantation during endovascular treatment for patients with emergent large vessel occlusion due to intracranial atherosclerotic stenosis is not inferior to that of balloon angioplasty, and it does not increase the risk of intracranial bleeding complications.

目的: 探讨急诊支架置入在颅内动脉粥样硬化性狭窄患者急性大动脉闭塞血管内治疗术中的有效性及安全性。 方法: 病例对照研究。回顾性分析2015年1月至2022年8月战略支援部队特色医学中心收治的严重颅内动脉粥样硬化狭窄导致急性大动脉闭塞患者46例的临床资料。所有患者均急诊行脑血管再通术,其中27例患者术中行单纯球囊成形,19例术中行急诊支架置入。通过对比两组患者的基线资料、术后责任血管改良脑梗死溶栓血流(mTICI)评分、术后90 d改良Rankin量表(mRS)评分、症状性颅内出血发生率及病死率,探讨颅内动脉粥样硬化性狭窄患者急性大动脉闭塞血管内治疗术中支架置入的疗效及安全性。 结果: 术后支架组患者责任血管获得有效再通(mTICI≥2b)的比例稍高于单纯球囊组[16/19 比 81.5%(22/27)],但差异无统计学意义(P>0.05)。术后90 d,支架组患者mRS中位数[3.0(0,4.0)]与单纯球囊组患者[4.0(1.0,5.0)]相比,差异无统计学意义(P>0.05)。在安全性方面,两组患者治疗后症状性颅内出血的发生率及病死率差异亦无统计学意义(P>0.05)。 结论: 颅内动脉粥样硬化性狭窄患者急性大动脉闭塞血管内治疗术中急诊支架置入术的疗效与单纯球囊成形术相当,且并不增加出血风险。.

Publication types

  • English Abstract

MeSH terms

  • Cerebral Infarction
  • Constriction, Pathologic
  • Humans
  • Intracranial Arteriosclerosis* / complications
  • Intracranial Hemorrhages* / etiology
  • Retrospective Studies